In re: The Merck & Co., Inc. Shareholder Litigation
GPTKB entity
Properties (64)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
legal case
|
| gptkbp:claims |
securities fraud
mismanagement |
| gptkbp:date |
2011
|
| gptkbp:decidedBy |
judge
|
| gptkbp:filedIn |
gptkb:United_States_District_Court
|
| gptkbp:filingDate |
2007
|
| gptkbp:involves |
gptkb:Merck_&_Co.,_Inc.
regulatory compliance board of directors confidentiality agreements financial reporting legal compliance evidence presentation legal representation witness testimonies financial settlements judicial review settlement agreement appeals process business practices case law legal precedents legal standards corporate policies investor protection investor relations legal documentation court procedures shareholder meetings financial disclosures class certification expert testimony court rulings legal fees litigation strategy fiduciary duty settlement negotiations discovery process corporate responsibility court jurisdiction trial proceedings litigation outcomes corporate accountability corporate ethics court filings class action financial integrity legal ramifications shareholder activism investor claims corporate litigation damages assessment settlement funds defendant responses disclosure issues financial damages plaintiff claims stockholder approval legal_arguments |
| gptkbp:issues |
corporate governance
|
| gptkbp:outcome |
settlement
|
| gptkbp:related_to |
shareholder rights
Vioxx_litigation |